Latest return on equity
Aurinia Pharmaceuticals Return on equity
Direct answer
Aurinia Pharmaceuticals's return on equity is 66.12%.
The verified market snapshot reports 66.12%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 66.12%
Explore related company data
View Aurinia Pharmaceuticals's market capitalizationView Aurinia Pharmaceuticals's p/e ratioView Aurinia Pharmaceuticals's price-to-book ratioView Aurinia Pharmaceuticals's dividend yieldView Aurinia Pharmaceuticals's 52-week price rangeView Aurinia Pharmaceuticals's revenue growthView Aurinia Pharmaceuticals's profit marginView Aurinia Pharmaceuticals's debt-to-equity ratioView all Aurinia Pharmaceuticals key metricsReturn to Aurinia Pharmaceuticals profile